Search Within

Alan Loh Ho

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (4)
  3. Editorial (1)
Groups
  1. Department of Medicine (12)
  2. GSK Faculty (12)
  3. Head and Neck Service (12)
  4. Molecular Pharmacology and Chemistry Program Faculty (12)
  5. Sloan Kettering Institute Faculty (12)
  6. Solid Tumor Oncology Division (12)

More Groups

People
  1. James Fagin (10)
  2. Ravinder Grewal (10)
  3. Steven Larson (10)
  4. Keith Pentlow (8)
  5. Ronald Ghossein (8)
  6. Robert Tuttle (7)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2022 (2)
  4. 2020 (2)
  5. 2019 (1)
  6. 2013 (1)

More Years

Publications
  1. European Journal of Nuclear Medicine and Molecular Imaging (3)
  2. Journal of Clinical Oncology (2)
  3. American Journal of Medical Genetics Part A (1)
  4. Cancer Discovery (1)
  5. EJNMMI Research (1)
  6. Journal of Clinical Endocrinology and Metabolism (1)

More Publications

Publishers
  1. Springer (4)
  2. American Society of Clinical Oncology (2)
  3. American Association for Cancer Research (1)
  4. Mary Ann Liebert, Inc (1)
  5. Massachusetts Medical Society (1)
  6. Oxford University Press (1)

More Publishers

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • [(18)F]TFB PET/CT misses intense [(124)I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer
    Journal Article

    Backhaus, P.; Pentlow, K. S.; Ho, A. L.; Mauguen, A.; Fagin, J. A.; Pillarsetty, N. V. K.; Lyashchenko, S. K.; Burnazi, E.; Ghossein, R. A.; Chhabra, S.; more...
    EJNMMI Research (2024)

    Fulltext@MSK | Save
  • Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: Overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs
    Editorial

    Bodei, L.; Tuttle, R. M.; Grewal, R. K.; Mauguen, A.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J. R.; Haque, S.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Prospective comparison of F-18-TFB and I-124 PET/CT in metastatic thyroid cancer
    Meeting Abstract

    Backhaus, P.; Pentlow, K.; Ho, A.; Mauguen, A.; Fagin, J.; Pillarsetty, N. V. K.; Lyashchenko, S.; Abusamra, M.; Larson, S.; Schoder, H.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Prospective comparison of F-18-TFB and I-124 PET/CT in metastatic thyroid cancer
    Meeting Abstract

    Backhaus, P.; Pentlow, K.; Ho, A. L.; Mauguen, A.; Fagin, J. A.; Pillarsetty, N. V. K.; Lyashchenko, S. K.; Burnazi, E.; Ghossein, R. A.; Chhabra, S.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): A regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
    Journal Article

    Mauguen, A.; Grewal, R. K.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J.; Haque, S.; Wong, B. Z. Y.; Ghossein, R. A.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the anti-ERBB3 monoclonal antibody CDX-3379: Results of a pilot clinical trial
    Journal Article

    Tchekmedyian, V.; Dunn, L.; Sherman, E.; Baxi, S. S.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers
    Journal Article

    Li, B. T.; Michelini, F.; Misale, S.; Cocco, E.; Baldino, L.; Cai, Y.; Shifman, S.; Tu, H. Y.; Myers, M. L.; Xu, C.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • The Sixth International RASopathies Symposium: Precision medicine - From promise to practice
    Journal Article

    Gripp, K. W.; Schill, L.; Schoyer, L.; Stronach, B.; Bennett, A. M.; Blaser, S.; Brown, A.; Burdine, R.; Burkitt-Wright, E.; Castel, P.; more...
    American Journal of Medical Genetics Part A (2020)

    Fulltext@MSK | Save
  • Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers
    Journal Article

    Dunn, L. A.; Sherman, E. J.; Baxi, S. S.; Tchekmedyian, V.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Journal of Clinical Endocrinology and Metabolism (2019)

    Fulltext@MSK | Save